期刊文献+

顶空气相色谱法测定西达本胺原料药中有机溶剂残留量

Determination of Residual Organic Solvents in Chidamide Bulk Drug by Headspace GC
下载PDF
导出
摘要 目的建立西达本胺原料药中4种残留溶剂的气相测定方法。方法采用顶空毛细管气相色谱法测定,SPB-1毛细管气相色谱柱(30m×0.32mm×0.5μm),进样口温度:180℃,进样量0.1mL,分流比1∶1;柱温:40℃,保持4min,12℃/min升温至100℃,再以40℃/min升温至220℃,保持4min;检测器为FID,温度:250℃;载气:N2,恒流:2mL·min-1;溶剂为N,N-二甲基乙酰胺。结果各残留溶剂均可以达到基线分离。测得甲醇、二氯甲烷和四氢呋喃线性关系良好。甲醇、二氯甲烷和四氢呋喃的平均回收率分别为98.23%(n=6)、97.87%(n=6)、99.15%(n=69)。结论该法操作简便,重现性好,结果准确可靠,可以用于西达本胺中残留溶剂的测定。 OBJECTIVE To establish a method to determine residual solvents in Chidamide bulk drug.METHODS The headspace GC was carried out with SPB-1 capillary column(30m×0.32mm×0.5μm).The inlet temperature was 180℃.The injection volume was 0.1mL and separation ratio was 1∶1.The column temperature was programmed:the initial temperature was 40℃,maintained for 4min,raised to 100℃with a rate of 12℃/min,and raised to 220℃with a rate of 40℃/min,then maintained for another 4min.The detector was FID with the temperature of 250℃.The carrying gas was N2 with the flow rate of 2mL·min^-1.DMA was used as solvent for Chidamide.RESULTS All solvents can be separated completely with good linear relationship.The average recoveries of acetone,acetonitrile,methylbenzene were 98.23%(n=9),97.87%(n=9),99.15%(n=9)respectively.CONCLUSION This method is simple,reproducible and accurate enough for determination of residual solvents in Chidamide bulk drug.
作者 朱克旭 张海波 ZHU Ke-xu;ZHANG Hai-bo(Chuzhou Food and Drug Inspection Center,Chuzhou 239000,China;Benxi Institute for Durg Control,Benxi 117000,China)
出处 《海峡药学》 2019年第1期59-61,共3页 Strait Pharmaceutical Journal
关键词 西达本胺 残留溶剂 顶空气相色谱法 Chidamide Residual solvent Headspace GC
  • 相关文献

参考文献7

二级参考文献38

  • 1尹子卉,吴仲闻,兰玉坤,廖晨钟,山松,李志良,宁志强,鲁先平,李志斌.新型抗肿瘤组蛋白去乙酰化酶抑制剂西达本胺的合成[J].中国新药杂志,2004,13(6):536-538. 被引量:8
  • 2周海钧.药品注册的国际技术要求(质量部分)[M].北京:人民卫生出版社,2000:87.
  • 3[1]Pazin MJ, Kadonaga JT. What' s Up and Down with Histone Deacetylation and Transcription [ J ]. Cell, 1997,89 (2): 325 - 328.
  • 4[2]Saito A, Yamashita T, Mariko Y, et al. A synthetic inhibitor of histone deacetylase,MS-27-275,with marked in vivo antitumor activity against human tumors [ J ]. PNAS, 1999, 96 ( 8 ): 4592 -4597.
  • 5[3]Lu XP, Li ZB, Xie AH, et al. Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and antiproliferation activity[P]. US P: US60/447915,2003 - 03 - 28.
  • 6[4]Silvio M,Antonello M,Gianluca S, et al. 3-(4-Aroyl-1 H-pyrrol2-yl)-N-hydroxy -2-propenamides, a new class of synthetic histone deacetylase inhibitors [ J ]. J Med Chem, 2001,44 ( 13 ):2069 - 2072.
  • 7[5]Tsuneji S,Tomoyuki A,Katsutoshi T,et al. Method of producing benzamide derivatives[ P]. EP:0 974 576 A2,2000- 01 -26.
  • 8周海钧.药品注册的国际技术要求[M].北京:人民卫生出版社,2007:129-133.
  • 9KinoT,HatanakaH,HashimotoH,etal.FK506,anovelimmunosuppressantisolatedfromaStreptomycesI.Fermentation,isolation,andphysico-chemicalandbiologicalcharacteristic[J].JAntibiot,1987,40(9):1249.
  • 10TanakaH,KurodaA,MarusawaH,etal.PhysicochemicalpropertiesofFK506,anovelimmunosuppressantisolatedfromStreptomycestsukbaensis[J].TransplantProc,1987,4(5,Suppl6):11.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部